Brief: Lavipharm SA FY 2025 Earnings After Tax EUR 6.0 Million Versus EUR 9.0 Million Year Ago
19/03/2026 15:30
March 19 (Reuters) - Lavipharm SA LPHr.AT: FY 2025 EARNINGS AFTER TAX EUR 6.0 MILLION VERSUS EUR 9.0 MILLION YEAR AGO FY 2025 ADJUSTED EBITDA FROM CONTINUING AND DISCONTINUED OPERATIONS AT EUR 15.5 MILLION VERSUS EUR 10.4 MILLION YEAR AGO FY 2025 TOTAL SALES BEFORE CLAWBACKS-REBATES FROM CONTINUING OPERATIONS AT EUR 70.0 MILLION VERSUS EUR 61.0 MILLION YEAR AGO Further company coverage: [LPHr.AT] (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 587785269;))
Recent news on Lavipharm SA
See all newsBrief: Lavipharm Q1 Earnings Before Tax From Continuing Operations €1.41 Million, Up 28.6% YoY
Brief: Lavipharm To Acquire Durogesic Pain Patch Rights From Janssen For $12.0 Million
Brief: Lavipharm SA FY 2025 Earnings After Tax EUR 6.0 Million Versus EUR 9.0 Million Year Ago
Brief: Lavipharm 9-Month Net Profit Down To EUR 3.5 Million
Brief: Lavipharm H1 Adjusted EBITDA At EUR 7.7 Million, Up 29.4% YoY